share_log

Biomarin Pharmaceutical(BMRN.US) Director Sells US$3.65 Million in Common Stock

moomoo News ·  Apr 15 17:04

$Biomarin Pharmaceutical (BMRN.US)$ Director BIENAIME JEAN JACQUES sold 40,000 shares of common stock on Apr 11, 12, 2024 at an average price of $91.13 for a total value of $3.65 million.

1713215063654152983.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment